In rheumatoid arthritis, miR‐221 was higher in patients with high disease activity, and the reduction of inflammatory cytokines (TNFa, IL‐6, and IL‐1β) by inhibition of miR‐221 suggests that it may be a target for treatment.18, 59. Here, IL6 is linked to rheumatoid arthritis.